Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients: FDA
TUESDAY, June 16, 2020 -- The drugs promoted by President Donald Trump as treatments for COVID-19 should not be used with the experimental drug remdesivir because of a potentially unfavorable drug interaction, the U.S. Food and Drug Administration...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: American Health | COVID-19 | Food and Drug Administration (FDA) | General Medicine | Hydroxychloroquine | Trump | USA Health